INVO Fertility
IVF | NASDAQ
$2.40
-$0.20 (-7.69%)
At close: Nov 16, 2026, 4:00 PM ET
$2.27
-$0.13 (-5.35%)
After-hours:
Nov 16, 2026, 7:46 PM ET
INVO Fertility Company Profile
Company profile explainedCompany Profile
INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services. Beyond this core business, the company actively develops clinical-stage therapies targeting oncology and autoimmune disorders. The firm was established on January 5, 2007, and its operations are based in Sarasota, Florida.
Key Executives
| Name | Position |
|---|---|
| Steven Shum | Chief Executive Officer & Director |
| Terah Krigsvold | Chief Financial Officer |
| Andrea Goren | Chief Business Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 04, 2026 | 8-K | Current Report |
| Jun 02, 2026 | 8-K | Current Report |
| Jun 02, 2026 | 10-K | Annual Report |
| Jun 02, 2026 | 8-K | Current Report |
| May 18, 2026 | NT 10-Q | Filing |
| May 15, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Apr 29, 2026 | 8-K | Current Report |
| Apr 01, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Apr 01, 2026 | NT 10-K | Filing |
| Mar 31, 2026 | 8-K | Current Report |
INVO Fertility
| Country | United States |
| IPO Date | Nov 2, 2020 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 41 |
| CEO | Steven Shum |
Contact Details
5582 Broadcast Court Sarasota,
Florida 34240 United States
Stock Details
| Ticker Symbol | IVF |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001417926 |
| CUSIP Number | 44984F872 |
| ISIN Number | US44984F8721 |
| SIC Code | 3841 |
Recent News
- 12 days ago / globenewswire.comINVO Fertility Partners with PatientFi to Help Make Fertility Treatment More Affordable
- 20 days ago / globenewswire.comINVO Fertility Announces a 1:4 Reverse Stock Split Effective Pre-Market Opening on October 30, 2026
- 2 months ago / globenewswire.comINVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference
- 3 months ago / globenewswire.comINVO Fertility to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
- 3 months ago / globenewswire.comINVO Fertility Announces Five Poster Presentations Highlighting Platelet-Rich Plasma Research at the 2026 Midwest Reproductive Symposium International
- 3 months ago / benzinga.comINVO Fertility Stock Surges Following Q2 Earnings Beat
- 3 months ago / globenewswire.comINVO Fertility Reports Second Quarter 2026 Results Highlighting Revenue Growth and Clinic Platform Profitability
Add to Watchlist
Select watchlists to add or remove IVF